Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Re Contract

1 Jun 2005 07:00

Torex Retail PLC01 June 2005 1 June 2005 Torex Retail plc Petroleum & Convenience Division Announces Somerfield Contract Win Torex Retail, a leading provider of IT solutions to major European retailers,today announces that it has won a two year, £3.3 million order with Somerfieldto implement its market leading PoS solution 'Iridium' and back office system 'Prism' into 225 stores across the UK. The solution will be rolled out to both convenience and petrol conveniencesites, including the newly announced stores to be acquired by Somerfield fromTexaco and Fuelforce. Both Iridium and Prism are highly functional, easy to useand can be seamlessly integrated into the Somerfield head office. Commenting on the decision to award the contract to Torex Retail, Tom Scott ofSomerfield said; "Torex Retail was able to provide us with a fully integrated and highlyfunctional solution which is already well proven within the Petroleum &Convenience marketplace. I believe that the overall roll out of the solutionwill increase the overall operating efficiency and profitability of our stores". Chris Moore, CEO of Torex Retail, said: "Our Petroleum and Convenience ('P&C') products are the market leaders in the UKand this win further strengthens our position within the P&C sector. We areconfident that through the combination of both our P&C PoS solution 'Iridium'and our back office system 'Prism', Somerfield's convenience and petrolconvenience stores will be able to achieve substantial operating efficienciesand tangible benefits in the future". Ends Enquiries:Chris Moore, CEORichard Thompson, Group Finance DirectorTorex Retail plcTel: 0870 050 9900 Or Seb Hoyle / Ginny PulbrookCitigate Dewe RogersonTel: 020 7638 9571 About Somerfield Somerfield is a high street retailer offering high quality groceries - with aparticular emphasis on fresh foods. Its stores offer a modern retail environmentwith the latest in-store facilities and a comprehensive range of products inconvenient neighbourhood locations. In the current competitive food retail market Somerfield has focused on itsclear strength in providing shoppers with an easy alternative to the largerout-of-town supermarkets, while maintaining its commitment to fresh qualityfoods. The Somerfield Convenience Brand, Essentials, operates 93 forecourts andConvenience Stores and with the addition of the Texaco and Fuelforceacquisitions that have been announced, the portfolio will increase to 233 by theend of July. About Torex Retail plc - www.torexretail.com Torex Retail plc is a leading independent provider of retail technologysolutions to many of the UK and Europe's leading retailers. In Spring 2004 thecompany was bought out from healthcare software provider Torex plc andre-floated on London's Alternative Investment Market with a marketcapitalisation of more than £100m. Torex's Retail's product and solution setspans high street and out-of-town retail and the petroleum and conveniencesectors and the company's customers include Dixons, Woolworth, Selfridges, Shelland Argos. The company's products cover PoS and a range of in-store and headoffice, loss prevention, logistics and performance and productivity solutions.Torex Retail has more than 1,000 staff based in the UK, Germany, Benelux andEire. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Nov 20227:00 amRNSDistribution agreement - OrthoPure® XT in Germany
14th Nov 20226:05 pmRNSHolding(s) in Company
7th Nov 20222:35 pmRNSHolding(s) in Company
29th Sep 202210:13 amRNSDirector/PDMR Shareholding
27th Sep 20227:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Operating leverage
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20223:31 pmRNSHolding(s) in Company
18th Aug 20225:36 pmRNSHolding(s) in Company
18th Aug 20222:10 pmRNSHolding(s) in Company
11th Aug 20224:30 pmEQSHardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct
11th Aug 202212:46 pmRNSHolding(s) in Company
11th Aug 202212:17 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSConfirmation of Interim Results
5th Aug 20223:19 pmRNSHolding(s) in Company
1st Aug 20223:14 pmRNSHolding(s) in Company
19th Jul 20222:30 pmEQSHardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential
19th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
18th Jul 20222:42 pmRNSHolding(s) in Company
18th Jul 20221:33 pmRNSHolding(s) in Company
15th Jul 20225:29 pmRNSHolding(s) in Company
27th Jun 20226:04 pmRNSHolding(s) in Company
27th Jun 202212:58 pmRNSHolding(s) in Company
16th Jun 20221:27 pmRNSExercise of Options and Total Voting Rights
28th Apr 20227:00 amRNSOrthoPure®XT clinical results presentation
26th Apr 20224:19 pmRNSResult of AGM
20th Apr 20224:26 pmRNSDirector/PDMR Shareholding
19th Apr 20227:15 amEQSHardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability
8th Apr 20227:00 amRNSGrant of share options
6th Apr 20222:59 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSFinal year results for the year ended 31 Dec 2021
9th Mar 20227:00 amRNSDistribution agreement for OrthoPure® XT
2nd Mar 20227:00 amRNSNotice of Results
10th Feb 20223:45 pmRNSAdditional Director Disclosures
27th Jan 20227:00 amRNSFull Year Trading update
23rd Dec 20217:00 amRNSDirector/PDMR Shareholding
21st Dec 20212:06 pmRNSSecond Price Monitoring Extn
21st Dec 20212:01 pmRNSPrice Monitoring Extension
19th Oct 20211:15 pmEQSHardman & Co Research: Tissue Regenix (TRX): Faster-than-anticipated recovery
8th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20214:44 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSHolding(s) in Company
24th Sep 20212:05 pmRNSDirector/PDMR Shareholding
9th Sep 20214:35 pmRNSDirector/PDMR Shareholding
8th Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSLaunch of DermaPure® Meshed and VNEWTM
1st Sep 20217:00 amRNSNotice of Results
16th Aug 20217:00 amRNSHolding(s) in Company
14th Jul 20213:15 pmEQSHardman & Co Research: Q&A with Dr Martin Hall on Tissue Regenix Group Plc: New capacity now on stream
30th Jun 202111:56 amEQSHardman & Co Research: Tissue Regenix (TRX): Poised for growth
29th Jun 20211:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.